4
Changes in Ownership
MoonLake Immunotherapeutics Filed Acc 0001213900-25-005686
Chief Scientific Officer acquired 111,949 shares (conversion)
- Chief Scientific Officer returned 111,949 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Reich Kristian Chief Scientific Officer | 2025-01-20 | Conversion | +111,949 | 153,930 | D | ||
| Reich Kristian Chief Scientific Officer | 2025-01-20 | Returned to the company | −111,949 | 84,367 | D | ||
| Derivatives | |||||||
| Reich Kristian Chief Scientific Officer | 2025-01-20 | Conversion · Common shares, par value CHF 0.10 per share, of MoonLake AG | −3,328 | 2,508 | D | ||
Loading xslF345X05/ownership.xml…